Medical devices and airport scanners maker Smiths Group says sales have been strong at its engineering unit John Clare, but revenues have been hit in the divisions exposed to government budget cuts.
For the half year to the end of January headline revenues increased by 3%, or £43m, to £1,415m, almost bang on the number forecast by analysts at Credit Suisse. Underlying sales grew 1%, or £13m.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The increase in revenues was driven primarily by growth at John Crane (up £55m), and Flex-Tek (up £2m) but suffered from declines at Smiths Detection (down £28m), Smiths Interconnect (down £11m) and Smiths Medical (down £5m).
Smiths has boosted the interim dividend by 4% to 11.75p per share.
Commenting on the results, Chief Executive Philip Bowman described performance at Smiths Detection and Interconnect as "disappointing". He added: "Remediation in Smiths Detection is on track, although the benefits will be weighted to the second half. Elsewhere, John Crane continues to report strong growth driven by investment in oil and gas infrastructure. Performance at Flex-Tek was encouraging and Smiths Medical has been resilient against a tough trading backdrop."
The market seemed unimpressed with the results; Smiths' shares dropped 2% at the open.
BS
-
How much gold does China have – and how to cash inChina's gold reserves are vastly understated, says Dominic Frisby. So hold gold, overbought or not
-
Scammers steal over £600 million from Brits - how to protect yourselfFraud cases in the first half of the year surged by 17% compared to the same period in 2024. Is your money at risk?
